Results
Sixty-four transgender and gender-diverse individuals (median [IQR] age, 22.5 [20-27] years) were enrolled. Eighty-eight individuals were invited to participate; 12 individuals were excluded due to current or previous testosterone treatment, 2 were excluded due to age younger than 18 years, and 10 declined to participate (